3 unknown. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Unknown 3 |
| Phase 2 | 1 | Unknown 1 |
Follow Effexus Pharmaceutical: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Safety and Tolerability of Secretrol in Patients With Barrett's Esophagus Secretrol - Barrett's Esophagus | Phase 1 | Unknown | Effexus Pharmaceutical | 13 | 2013-04-01 | 2014-08-04 |
| Safety of Secretrol® in the Short-term Management of Patients Undergoing Endoscopic Mucosal Resection (EMR) Secretrol - EMR Ulcer | Phase 1 | Unknown | Effexus Pharmaceutical | 5 | 2013-04-01 | 2014-08-06 |
| Comparison of Nexium Versus Secretol in the Healing and Controlling of Symptoms in GERD Patients With Severe EE. Secretol, Nexium - Gastroesophageal Reflux Disease (GERD), Heartburn | Phase 1 / Phase 2 | Unknown | Effexus Pharmaceutical | 40 | 2010-05-01 | 2014-08-05 |
Barrett Esophagus (1) · Dyspepsia (1) · Gastroesophageal Reflux (1) · Heartburn (1)
Esomeprazole (1) · Lansoprazole (1)
United States (3)
Prateek Sharma, M.D. (1) · Ronnie Fass, MD (1)